Article
1-year results from HELIOS trial show stability or improvement in treating NPDR
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
FDA grants fast track designation to N-acetylcysteine amide tablets from Nacuity Pharmaceuticals
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study reveals temperature fluctuations at home may compromise anti-VEGF drug safety
BLINK2 study confirms lasting myopia control benefits in teenagers